Role of miRNAs in Rheumatoid Arthritis Therapy
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by autoimmunity, synovial inflammation and joint destruction. Pannus formation in the synovial cavity can cause irreversible damage to the joint and cartilage and eventually permanent disability. Current conventional...
Main Authors: | Yiping Zhang, Meiwen Yang, Hongyan Xie, Fenfang Hong, Shulong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/13/1749 |
Similar Items
-
miRNAs and rheumatoid arthritis – promising novel biomarkers
by: I Duroux-Richard, et al.
Published: (2011-03-01) -
Serum miRNA Signature in Rheumatoid Arthritis and “At-Risk Individuals”
by: Clare C. Cunningham, et al.
Published: (2021-03-01) -
miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
by: Tomasz Kmiołek, et al.
Published: (2022-01-01) -
The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritis
by: Ning-Sheng Lai, et al.
Published: (2017-12-01) -
Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside
by: Jinghua Wang, et al.
Published: (2020-01-01)